G protein-coupled receptors and the modification of FcɛRI-mediated mast cell activation

Galli, 2005, Mast cells in the development of adaptive immune responses, Nat Immunol, 6, 135, 10.1038/ni1158

Marshall, 2004, Mast-cell responses to pathogens, Nat Rev Immunol, 4, 787, 10.1038/nri1460

Tkaczyk, 2006, Adaptive and innate immune reactions regulating mast cell activation: from receptor-mediated signaling to responses, Immunol Allergy Clin North Am, 26, 427, 10.1016/j.iac.2006.05.011

Metcalfe, 1997, Mast cells, Physiol Rev, 77, 1033, 10.1152/physrev.1997.77.4.1033

Metzger, 1992, The receptor with high affinity for IgE, Immunol Rev, 125, 37, 10.1111/j.1600-065X.1992.tb00624.x

Gilfillan, 2006, Integrated signalling pathways for mast-cell activation, Nat Rev Immunol, 6, 218, 10.1038/nri1782

Fujishima, 1999, Cytosolic phospholipase A2 is essential for both the immediate and the delayed phases of eicosanoid generation in mouse bone marrow-derived mast cells., Proc Natl Acad Sci USA, 96, 4803, 10.1073/pnas.96.9.4803

Tkaczyk, 2004, NTAL phosphorylation is a pivotal link between the signaling cascades leading to human mast cell degranulation following Kit activation and FcɛRI aggregation, Blood, 104, 207, 10.1182/blood-2003-08-2769

Hundley, 2004, Kit and FcɛRI mediate unique and convergent signals for release of inflammatory mediators from human mast cells, Blood, 104, 2410, 10.1182/blood-2004-02-0631

Bischoff, 1992, c-kit ligand: a unique potentiator of mediator release by human lung mast cells, J Exp Med, 175, 237, 10.1084/jem.175.1.237

Iwaki, 2005, Btk plays a crucial role in the amplification of FcɛRI-mediated mast cell activation by kit, J Biol Chem, 280, 40261, 10.1074/jbc.M506063200

Galli, 1993, The c-kit receptor, stem cell factor, and mast cells. What each is teaching us about the others, Am J Pathol, 142, 965

Okayama, 2006, Development, migration, and survival of mast cells, Immunol Res, 34, 97, 10.1385/IR:34:2:97

Qiao, 2006, FcɛR1 and toll-like receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells, Blood, 107, 610, 10.1182/blood-2005-06-2271

Taub, 1995, Bone marrow-derived murine mast cells migrate, but do not degranulate, in response to chemokines, J Immunol, 154, 2393, 10.4049/jimmunol.154.5.2393

Olivera, 2005, Sphingolipids and the balancing of immune cell function: lessons from the mast cell, J Immunol, 174, 1153, 10.4049/jimmunol.174.3.1153

Hughes, 1984, Adenosine inhibits and potentiates IgE-dependent histamine release from human lung mast cells by an A2-purinoceptor mediated mechanism, Biochem Pharmacol, 33, 3847, 10.1016/0006-2952(84)90050-9

Wang, 2006, E potentiates the immunologically stimulated histamine release from human peripheral blood-derived mast cells through EP1/EP3 receptors, Allergy, 61, 503, 10.1111/j.1398-9995.2006.01043.x

Kay, 2006, Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation, Br J Pharmacol, 147, 707, 10.1038/sj.bjp.0706664

Feng, 2006, Human mast cells express multiple EP receptors for prostaglandin E2 that differentially modulate activation responses, Blood, 107, 3243, 10.1182/blood-2005-07-2772

Bockaert, 1999, Molecular tinkering of G protein-coupled receptors: an evolutionary success, EMBO J, 18, 1723, 10.1093/emboj/18.7.1723

Wess, 1997, G-protein-coupled receptors: molecular mechanisms involved in receptor activation and selectivity of G-protein recognition, FASEB J, 11, 346, 10.1096/fasebj.11.5.9141501

Hamm, 1996, Heterotrimeric G proteins, Curr Opin Cell Biol, 8, 189, 10.1016/S0955-0674(96)80065-2

Gilman, 1987, G proteins: transducers of receptor-generated signals, Annu Rev Biochem, 56, 615, 10.1146/annurev.bi.56.070187.003151

Simon, 1991, Diversity of G proteins in signal transduction, Science, 252, 802, 10.1126/science.1902986

Bence, 1997, Direct stimulation of Bruton's tyrosine kinase by G(q)-protein α-subunit, Nature, 389, 296, 10.1038/38520

Kehrl, 1998, G protein signaling: roles in immune function and fine-tuning by RGS proteins, Immunity, 8, 1, 10.1016/S1074-7613(00)80453-7

Albert, 2002, G protein specificity: traffic direction required, Cell Signal, 14, 407, 10.1016/S0898-6568(01)00259-5

Clapham, 1997, G protein βγ subunits, Annu Rev Pharmacol Toxicol, 37, 167, 10.1146/annurev.pharmtox.37.1.167

Papadopoulos, 2000, Mast cells migrate, but do not degranulate, in response to fractalkine, a membrane-bound chemokine expressed constitutively in diverse cells of the skin, Eur J Immunol, 30, 2355, 10.1002/1521-4141(2000)30:8<2355::AID-IMMU2355>3.0.CO;2-#

Romagnani, 1999, Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines, Am J Pathol, 155, 1195, 10.1016/S0002-9440(10)65222-4

Kushnir-Sukhov, 2006, 5-Hydroxytryptamine induces mast cell adhesion and migration, J Immunol, 177, 6422, 10.4049/jimmunol.177.9.6422

Ali, 2005, Anaphylatoxin C3a receptors in asthma, Respir Res, 6, 19, 10.1186/1465-9921-6-19

Hartmann, 1997, C3a and C5a stimulate chemotaxis of human mast cells, Blood, 89, 2863, 10.1182/blood.V89.8.2863

Thangam, 2005, Airway smooth muscle cells enhance C3a-induced mast cell degranulation following cell-cell contact, FASEB J, 19, 798, 10.1096/fj.04-2797fje

Venkatesha, 2005, Distinct regulation of C3a-induced MCP-1/CCL2 and RANTES/CCL5 production in human mast cells by extracellular signal regulated kinase and PI3 kinase, Mol Immunol, 42, 581, 10.1016/j.molimm.2004.09.009

Erdei, 1995, Complement peptide C3a inhibits IgE-mediated triggering of rat mucosal mast cells, Int Immunol, 7, 1433, 10.1093/intimm/7.9.1433

Andrasfalvy, 2005, The beta subunit of the type I Fcɛ receptor is a target for peptides inhibiting IgE-mediated secretory response of mast cells, J Immunol, 175, 2801, 10.4049/jimmunol.175.5.2801

Woolhiser, 2004, Activation of human mast cells by aggregated IgG through FcγRI: additive effects of C3a, Clin Immunol, 110, 172, 10.1016/j.clim.2003.11.007

Mousli, 1992, A mechanism of action for anaphylatoxin C3a stimulation of mast cells, J Immunol, 148, 2456, 10.4049/jimmunol.148.8.2456

Nilsson, 1996, C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway, J Immunol, 157, 1693, 10.4049/jimmunol.157.4.1693

Goetzl, 2004, Sphingosine 1-phosphate and its G protein-coupled receptors constitute a multifunctional immunoregulatory system, J Cell Biochem, 92, 1104, 10.1002/jcb.20053

Rosen, 2005, Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network, Nat Rev Immunol, 5, 560, 10.1038/nri1650

Olivera, 2006, IgE-dependent activation of sphingosine kinases 1 and 2 and secretion of sphingosine 1-phosphate requires Fyn kinase and contributes to mast cell responses, J Biol Chem, 281, 2515, 10.1074/jbc.M508931200

Jolly, 2004, Transactivation of sphingosine-1-phosphate receptors by FcɛRI triggering is required for normal mast cell degranulation and chemotaxis, J Exp Med, 199, 959, 10.1084/jem.20030680

Siehler, 2002, Pathways of transduction engaged by sphingosine 1-phosphate through G protein-coupled receptors, Biochim Biophys Acta, 1582, 94, 10.1016/S1388-1981(02)00142-7

Lee, 2005, Antigen-induced Ca2+mobilization in RBL-2H3 cells: role of I(1,4,5)P3 and S1P and necessity of I(1,4 5)P3 production., Cell Calc, 38, 581, 10.1016/j.ceca.2005.08.002

Choi, 1996, Calcium mobilization via sphingosine kinase in signalling by the FcɛRI antigen receptor, Nature, 380, 634, 10.1038/380634a0

Jolly, 2005, Expression of SphK1 impairs degranulation and motility of RBL-2H3 mast cells by desensitizing S1P receptors, Blood, 105, 4736, 10.1182/blood-2004-12-4686

Matsuyuki, 2006, Involvement of sphingosine 1-phosphate (S1P) receptor type 1 and type 4 in migratory response of mouse T cells toward S1P, Cell Mol Immunol, 3, 429

Mitra, 2006, Role of ABCC1 in export of sphingosine-1-phosphate from mast cells, Proc Natl Acad Sci USA, 103, 16394, 10.1073/pnas.0603734103

Olivera, 2007, The sphingosine kinase-sphingosine-1-phosphate axis is a determinant of mast cell function and anaphylaxis, Immunity, 26, 287, 10.1016/j.immuni.2007.02.008

Bagga, 2004, Lysophosphatidic acid accelerates the development of human mast cells, Blood, 104, 4080, 10.1182/blood-2004-03-1166

Lin, 2005, IL-4 regulates MEK expression required for lysophosphatidic acid-mediated chemokine generation by human mast cells, J Immunol, 175, 5430, 10.4049/jimmunol.175.8.5430

Hashimoto, 2006, Lysophosphatidic acid (LPA) induces plasma exudation and histamine release in mice via LPA receptors, J Pharmacol Sci, 100, 82, 10.1254/jphs.FPJ05030X

Hashimoto, 2005, Lysophosphatidic acid induces histamine release from mast cells and skin fragments, Pharmacology, 75, 13, 10.1159/000085784

Marshall, 1999, Nerve growth factor modifies the expression of inflammatory cytokines by mast cells via a prostanoid-dependent mechanism, J Immunol, 162, 4271, 10.4049/jimmunol.162.7.4271

Harris, 2002, Prostaglandins as modulators of immunity, Trends Immunol, 23, 144, 10.1016/S1471-4906(01)02154-8

Vancheri, 2004, The lung as a privileged site for the beneficial actions of PGE2, Trends Immunol, 25, 40, 10.1016/j.it.2003.11.001

Sugimoto, 2007, E receptors, J Biol Chem, 282, 11613, 10.1074/jbc.R600038200

Gomi, 2000, Prostaglandin E2 selectively enhances the IgE-mediated production of IL-6 and granulocyte-macrophage colony-stimulating factor by mast cells through an EP1/EP3-dependent mechanism, J Immunol, 165, 6545, 10.4049/jimmunol.165.11.6545

Nguyen, 2002, Receptors and signaling mechanisms required for prostaglandin E2-mediated regulation of mast cell degranulation and IL-6 production, J Immunol, 169, 4586, 10.4049/jimmunol.169.8.4586

Polosa, 2006, Adenosine receptors as promising therapeutic targets for drug development in chronic airway inflammation, Curr Drug Targets, 7, 699, 10.2174/138945006777435236

Driver, 1993, Adenosine in bronchoalveolar lavage fluid in asthma, Am Rev Respir Dis, 148, 91, 10.1164/ajrccm/148.1.91

Forsythe, 1999, Adenosine, mast cells and asthma, Inflamm Res, 48, 301, 10.1007/s000110050464

Laffargue, 2002, Phosphoinositide 3-kinase γ is an essential amplifier of mast cell function, Immunity, 16, 441, 10.1016/S1074-7613(02)00282-0

Gilfillan, 1990, Pertussis toxin pretreatment reveals differential effects of adenosine analogs on IgE-dependent histamine and peptidoleukotriene release from RBL-2H3 cells, Biochim Biophys Acta, 1052, 467, 10.1016/0167-4889(90)90157-9

Ramkumar, 1993, The A3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells, J Biol Chem, 268, 16887, 10.1016/S0021-9258(19)85277-8

Ryzhov, 2006, Cross-talk between G(s)- and G(q)-coupled pathways in regulation of interleukin-4 by A(2B) adenosine receptors in human mast cells, Mol Pharmacol, 70, 727, 10.1124/mol.106.022780

Feoktistov, 1995, Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells An enprofylline-sensitive mechanism with implications for asthma., J Clin Invest, 96, 1979, 10.1172/JCI118245

Duffy, 2007, Adenosine closes the K+channel KCa3 1 in human lung mast cells and inhibits their migration via the adenosine A2A receptor., Eur J Immunol, 37, 1653, 10.1002/eji.200637024

Zhong, 2003, Activation of murine lung mast cells by the adenosine A3 receptor, J Immunol, 171, 338, 10.4049/jimmunol.171.1.338

Suzuki, 1998, Inhibitory effect of adenosine on degranulation of human cultured mast cells upon cross-linking of FcɛRI, Biochem Biophys Res Commun, 242, 697, 10.1006/bbrc.1997.8040

Linden, 1999, Characterization of human A(2B) adenosine receptors: radioligand binding, Western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells, Mol Pharmacol, 56, 705

Salvatore, 2000, Disruption of the A(3) adenosine receptor gene in mice and its effect on stimulated inflammatory cells, J Biol Chem, 275, 4429, 10.1074/jbc.275.6.4429

Yamano, 2005, Human adenosine A(3) receptor leads to intracellular Ca(2+) mobilization but is insufficient to activate the signaling pathway via phosphoinositide 3-kinase gamma in mice, Biochem Pharmacol, 70, 1487, 10.1016/j.bcp.2005.08.003

Abbracchio, 1994, Purinoceptors: are there families of P2X and P2Y purinoceptors?, Pharmacol Ther, 64, 445, 10.1016/0163-7258(94)00048-4

Dubyak, 1993, Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides, Am J Physiol, 265, C577, 10.1152/ajpcell.1993.265.3.C577

Feng, 2004, Adenine nucleotides inhibit cytokine generation by human mast cells through a Gs-coupled receptor, J Immunol, 173, 7539, 10.4049/jimmunol.173.12.7539

Jaffar, 1990, Histamine secretion from mast cells stimulated with ATP, Agents Actions, 30, 64, 10.1007/BF01968999

Saito, 1991, The stimuli releasing histamine from murine bone marrow-derived mast cells. 2. Mechanisms involved in histamine release induced by extracellular ATP and its metabolites, Arerugi, 40, 680

Osipchuk, 1992, Cell-to-cell spread of calcium signals mediated by ATP receptors in mast cells, Nature, 359, 241, 10.1038/359241a0

Schulman, 1999, ATP modulates anti-IgE-induced release of histamine from human lung mast cells, Am J Respir Cell Mol Biol, 20, 530, 10.1165/ajrcmb.20.3.3387

Nakajima, 2002, Marked increase in CC chemokine gene expression in both human and mouse mast cell transcriptomes following Fcɛ receptor I cross-linking: an interspecies comparison, Blood, 100, 3861, 10.1182/blood-2002-02-0602

Kambayashi, 2007, Proximal signaling events in FcɛRI-mediated mast cell activation, J Allergy Clin Immunol, 119, 544, 10.1016/j.jaci.2007.01.017

Zlotnik, 2000, Chemokines: a new classification system and their role in immunity, Immunity, 12, 121, 10.1016/S1074-7613(00)80165-X

Murray, 2006, Role of chemokines in severe asthma, Curr Drug Targets, 7, 579, 10.2174/138945006776818674

Romagnani, 2002, Cytokines and chemoattractants in allergic inflammation, Mol Immunol, 38, 881, 10.1016/S0161-5890(02)00013-5

Pease, 2006, Asthma, allergy and chemokines, Curr Drug Targets, 7, 3, 10.2174/138945006775270204

Zhao, 2001, Mast cell degranulation and the role of T cell RANTES in oral lichen planus, Oral Dis, 7, 246, 10.1034/j.1601-0825.2001.70408.x

Castellani, 2006, Rat basophilic leukemia cells (RBL-2H3) generate prostaglandin D2 (PGD2) after regulated upon activation, normal T-cell expressed and secreted (RANTES) activation, Int J Biol Markers, 21, 211, 10.1177/172460080602100403

Juremalm, 2002, Selective CCL5/RANTES-induced mast cell migration through interactions with chemokine receptors CCR1 and CCR4, Biochem Biophys Res Commun, 297, 480, 10.1016/S0006-291X(02)02244-1

Toda, 2004, Impact of engagement of FcɛRI and CC chemokine receptor 1 on mast cell activation and motility, J Biol Chem, 279, 48443, 10.1074/jbc.M408725200

Miyazaki, 2005, Macrophage inflammatory protein-1α as a costimulatory signal for mast cell-mediated immediate hypersensitivity reactions, J Clin Invest, 115, 434, 10.1172/JCI18452

Waldeck, 2002, β-adrenoceptor agonists and asthma—100 years of development, Eur J Pharmacol, 445, 1, 10.1016/S0014-2999(02)01728-4

Peachell, 2006, Regulation of mast cells by β-agonists, Clin Rev Allergy Immunol, 31, 131, 10.1385/CRIAI:31:2:131

Wang, 2006, β-adrenoceptor-mediated inhibition of mediator release from human peripheral blood-derived mast cells, Clin Exp Pharmacol Physiol, 33, 746, 10.1111/j.1440-1681.2006.04435.x

Akabane, 2006, Effects of salmeterol xinafoate and fluticasone propionate on immunological activation of human cultured mast cells, Allergol Int, 55, 387, 10.2332/allergolint.55.387

Bissonnette, 1997, Anti-inflammatory effect of β2-agonists: inhibition of TNF-α release from human mast cells, J Allergy Clin Immunol, 100, 825, 10.1016/S0091-6749(97)70280-X

Weston, 1998, Regulation of human mast cell and basophil function by camp, Gen Pharmacol, 31, 715, 10.1016/S0306-3623(98)00080-9

Rivera, 2006, Molecular regulation of mast cell activation, J Allergy Clin Immunol, 117, 1214, 10.1016/j.jaci.2006.04.015

Kraft, 2007, New developments in FcɛRI regulation, function and inhibition, Nat Rev Immunol, 7, 365, 10.1038/nri2072

Kovarova, 2001, Structure–function analysis of Lyn kinase association with lipid rafts and initiation of early signaling events after Fcɛ receptor I aggregation, Mol Cell Biol, 21, 8318, 10.1128/MCB.21.24.8318-8328.2001

Field, 1999, Structural aspects of the association of FcɛRI with detergent-resistant membranes, J Biol Chem, 274, 1753, 10.1074/jbc.274.3.1753

Yamashita, 1994, Aggregation of the high-affinity IgE receptor and enhanced activity of p53/56lyn protein-tyrosine kinase, Proc Natl Acad Sci USA, 91, 11251, 10.1073/pnas.91.23.11251

Vonakis, 1997, The unique domain as the site on Lyn kinase for its constitutive association with the high affinity receptor for IgE, J Biol Chem, 272, 24072, 10.1074/jbc.272.38.24072

Eiseman, 1992, Engagement of the high-affinity IgE receptor activates src protein-related tyrosine kinases, Nature, 355, 78, 10.1038/355078a0

Chen, 1996, Interaction of phosphorylated FcɛRIγ immunoglobulin receptor tyrosine activation motif-based peptides with dual and single SH2 domains of p72syk. Assessment of binding parameters and real time binding kinetics, J Biol Chem, 271, 25308, 10.1074/jbc.271.41.25308

Saitoh, 2000, LAT is essential for FcɛRI-mediated mast cell activation, Immunity, 12, 525, 10.1016/S1074-7613(00)80204-6

Iwaki S, Jensen BM, Gilfillan AM. Ntal/Lab/Lat2. Int J Biochem Cell Biol 2007;39:868–73.

Rivera, 2005, NTAL/LAB and LAT: a balancing act in mast-cell activation and function, Trends Immunol, 26, 119, 10.1016/j.it.2005.01.001

Silverman, 2006, Disruption of SLP-76 interaction with Gads inhibits dynamic clustering of SLP-76 and FcɛRI signaling in mast cells, Mol Cell Biol, 26, 1826, 10.1128/MCB.26.5.1826-1838.2006

Rhee, 2001, Regulation of phosphoinositide-specific phospholipase C, Annu Rev Biochem, 70, 281, 10.1146/annurev.biochem.70.1.281

Beaven, 1993, Signal transduction by Fc receptors: the FcɛRI case, Immunol Today, 14, 222, 10.1016/0167-5699(93)90167-J

Bell, 1991, Lipid activation of protein kinase C, J Biol Chem, 266, 4661, 10.1016/S0021-9258(19)67698-2

Ozawa, 1993, Ca(2+)-dependent and Ca(2+)-independent isozymes of protein kinase C mediate exocytosis in antigen-stimulated rat basophilic RBL-2H3 cells. Reconstitution of secretory responses with Ca2+and purified isozymes in washed permeabilized cells, J Biol Chem, 268, 1749, 10.1016/S0021-9258(18)53916-8

Tkaczyk, 2003, The phospholipase Cγ1-dependent pathway of FcɛRI-mediated mast cell activation is regulated independently of phosphatidylinositol 3-kinase, J Biol Chem, 278, 48474, 10.1074/jbc.M301350200

Parravicini, 2002, Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation, Nat Immunol, 3, 741, 10.1038/ni817

Ali, 2004, Essential role for the p110δ phosphoinositide 3-kinase in the allergic response, Nature, 431, 1007, 10.1038/nature02991

Cantrell, 2001, Phosphoinositide 3-kinase signalling pathways, J Cell Sci, 114, 1439, 10.1242/jcs.114.8.1439

Cantley, 2002, The phosphoinositide 3-kinase pathway, Science, 296, 1655, 10.1126/science.296.5573.1655

Lu-Kuo, 2000, Impaired kit- but not FcɛRI-initiated mast cell activation in the absence of phosphoinositide 3-kinase p85α gene products, J Biol Chem, 275, 6022, 10.1074/jbc.275.8.6022

Gomez, 2005, Impaired FcɛRI-dependent gene expression and defective eicosanoid and cytokine production as a consequence of Fyn deficiency in mast cells, J Immunol, 175, 7602, 10.4049/jimmunol.175.11.7602

Bingham CO, 3rd, Austen KF. Phospholipase A2 enzymes in eicosanoid generation. Proc Assoc Am Phys 1999;111:516–24.

Lorentz, 2003, Role of activator protein 1, nuclear factor-κB, and nuclear factor of activated T cells in IgE receptor-mediated cytokine expression in mature human mast cells, J Allergy Clin Immunol, 111, 1062, 10.1067/mai.2003.1342

Kitaura, 2000, Akt-dependent cytokine production in mast cells, J Exp Med, 192, 729, 10.1084/jem.192.5.729

Fruman, 2002, Phosphoinositide 3-kinase in immunological systems, Semin Immunol, 14, 7, 10.1006/smim.2001.0337

Nakamura, 1989, The stimuli releasing histamine from murine bone marrow-derived mast cells. 1. The presence of P2-purinoceptors, Arerugi, 38, 1359

Budagian, 2003, Signaling through P2X7 receptor in human T cells involves p56lck, MAP kinases, and transcription factors AP-1 and NF-κB, J Biol Chem, 278, 1549, 10.1074/jbc.M206383200